Skip to main content
SpringerLink
Log in

Trigeminal Autonomic Cephalgias

  • Chapter
  • First Online:
Controversies in Neuro-Ophthalmic Management

  • 572 Accesses

Abstract

The term “trigeminal autonomic cephalgia” (TAC) encompasses five headache syndromes with distinct clinical features and time courses. These five headache disorders, considered primary headache disorders, include cluster headache (CH), short-lasting unilateral neuralgiform headache with conjunctival tearing and injection (SUNCT), short-lasing unilateral neuralgiform headache with cranial autonomic symptoms (SUNA), paroxysmal hemicrania (PH), and hemicrania continua (HC). In this chapter, we will review recent updates to TAC classifications and review new treatment modalities, including neuromodulation interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wei DY, Yuan Ong JJ, Goadsby PJ. Overview of trigeminal autonomic cephalalgias: nosologic evolution, diagnosis, and management. Ann Indian Acad Neurol. 2018;21(Suppl 1):S39–44.

    PubMed  PubMed Central  Google Scholar 

  2. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997;120(Pt 1):193–209.

    Article  PubMed  Google Scholar 

  3. Burish MJ, Rozen TD. Trigeminal autonomic cephalalgias. Neurol Clin. 2019;37(4):847–69.

    Article  PubMed  Google Scholar 

  4. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352(9124):275–8.

    Article  CAS  PubMed  Google Scholar 

  5. Frese A, Evers S, May A. Autonomic activation in experimental trigeminal pain. Cephalalgia. 2003;23(1):67–8.

    Article  CAS  PubMed  Google Scholar 

  6. Alstadhaug KB, Ofte HK. Cluster headache. Tidsskr Nor Laegeforen. 2015;135(15):1361–4.

    Article  PubMed  Google Scholar 

  7. Schytz HW, Barløse M, Guo S, Selb J, Caparso A, Jensen R, et al. Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia. 2013;33(10):831–41.

    Article  PubMed  Google Scholar 

  8. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002;125(Pt 5):976–84.

    Article  PubMed  Google Scholar 

  9. Burish M. Cluster headache and other trigeminal autonomic cephalalgias. Continuum (Minneap Minn). 2018;24(4, Headache):1137–56.

    Google Scholar 

  10. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117(Pt 3):427–34.

    Article  PubMed  Google Scholar 

  11. Gaul C, Diener HC, Silver N, Magis D, Reuter U, Andersson A, et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia. 2016;36(6):534–46.

    Google Scholar 

  12. Akerman S, Simon B, Romero-Reyes M. Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache. Neurobiol Dis. 2017;102:96–104.

    Article  PubMed  Google Scholar 

  13. Baumber L, Sjöstrand C, Leone M, Harty H, Bussone G, Hillert J, et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology. 2006;66(12):1888–93.

    Article  CAS  PubMed  Google Scholar 

  14. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

    Google Scholar 

  15. Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018;17(1):75–83.

    Article  PubMed  Google Scholar 

  16. Leone M, Giustiniani A, Cecchini AP. Cluster headache: present and future therapy. Neurol Sci. 2017;38(Suppl 1):45–50.

    Article  PubMed  Google Scholar 

  17. Mitsikostas DD, Ashina M, Craven A, Diener HC, Goadsby PJ, Ferrari MD, et al. European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5.

    Article  CAS  PubMed  Google Scholar 

  18. Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache. 2016;56(7):1093–106.

    Article  PubMed  Google Scholar 

  19. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004;56(4):488–94.

    Article  CAS  PubMed  Google Scholar 

  20. Robbins L. Intranasal lidocaine for cluster headache. Headache. 1995;35(2):83–4.

    Article  CAS  PubMed  Google Scholar 

  21. Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20(2):85–91.

    Article  CAS  PubMed  Google Scholar 

  22. Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2011;10(10):891–7.

    Article  CAS  PubMed  Google Scholar 

  23. Magis D, D'Ostilio K, Lisicki M, Lee C, Schoenen J. Anodal frontal tDCS for chronic cluster headache treatment: a proof-of-concept trial targeting the anterior cingulate cortex and searching for nociceptive correlates. J Headache Pain. 2018;19(1):72.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJ, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33(10):816–30.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Marin J, Giffin N, Consiglio E, McClure C, Liebler E, Davies B. Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience. J Headache Pain. 2018;19(1):114.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Wilbrink LA, Teernstra OP, Haan J, van Zwet EW, Evers SM, Spincemaille GH, et al. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia. 2013;33(15):1238–47.

    Article  PubMed  Google Scholar 

  27. Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000;54(6):1382–5.

    Article  CAS  PubMed  Google Scholar 

  28. Leone M, Dodick D, Rigamonti A, D’Amico D, Grazzi L, Mea E, et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia. 2003;23(10):1001–2.

    Article  CAS  PubMed  Google Scholar 

  29. Steiner TJ, Hering R, Couturier EG, Davies PT, Whitmarsh TE. Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia. 1997;17(6):673–5.

    Article  CAS  PubMed  Google Scholar 

  30. Hering-Hanit R, Gadoth N. Baclofen in cluster headache. Headache. 2000;40(1):48–51.

    Article  CAS  PubMed  Google Scholar 

  31. Prakash S, Belani P, Susvirkar A, Trivedi A, Ahuja S, Patel A. Paroxysmal hemicrania: a retrospective study of a consecutive series of 22 patients and a critical analysis of the diagnostic criteria. J Headache Pain. 2013;14:26.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Baraldi C, Pellesi L, Guerzoni S, Cainazzo MM, Pini LA. Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal. J Headache Pain. 2017;18(1):71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Lucas S. The pharmacology of indomethacin. Headache. 2016;56(2):436–46.

    Article  PubMed  Google Scholar 

  34. Jürgens TP, Schulte LH, May A. Indomethacin-induced de novo headache in hemicrania continua--fighting fire with fire? Cephalalgia. 2013;33(14):1203–5.

    Article  PubMed  Google Scholar 

  35. Walcott BP, Bamber NI, Anderson DE. Successful treatment of chronic paroxysmal hemicrania with posterior hypothalamic stimulation: technical case report. Neurosurgery. 2009;65(5):E997; discussion E.

    Google Scholar 

  36. Morelli N, Mancuso M, Felisati G, Lozza P, Maccari A, Cafforio G, et al. Does sphenopalatine endoscopic ganglion block have an effect in paroxysmal hemicrania? A case report. Cephalalgia. 2010;30(3):365–7.

    Article  CAS  PubMed  Google Scholar 

  37. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg. 2008;110(1):88–91.

    Article  PubMed  Google Scholar 

  38. Lisotto C, Maggioni F, Mainardi F, Zanchin G. Rofecoxib for the treatment of chronic paroxysmal hemicrania. Cephalalgia. 2003;23(4):318–20.

    Article  CAS  PubMed  Google Scholar 

  39. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. BMJ Case Rep. 2009;2009:bcr06.2009.2007.

    PubMed  PubMed Central  Google Scholar 

  40. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves. Funct Neurol. 1997;12(1):11–5.

    CAS  PubMed  Google Scholar 

  41. Tepper SJ, Tepper DE. The Cleveland Clinic Manual of Headache Therapy. 2nd ed. Switzerland: Springer International Publishing; 2014.

    Google Scholar 

  42. Spears RC. Is gabapentin an effective treatment choice for hemicrania continua? J Headache Pain. 2009;10(4):271–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Rozen TD. Melatonin responsive hemicrania continua. Headache. 2006;46(7):1203–4.

    Article  PubMed  Google Scholar 

  44. Rajabally YA, Jacob S. Hemicrania continua responsive to verapamil. Headache. 2005;45(8):1082–3.

    Article  PubMed  Google Scholar 

  45. Prakash S, Husain M, Sureka DS, Shah NP, Shah ND. Is there need to search for alternatives to indomethacin for hemicrania continua? Case reports and a review. J Neurol Sci. 2009;277(1–2):187–90.

    Article  CAS  PubMed  Google Scholar 

  46. Brighina F, Palermo A, Cosentino G, Fierro B. Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate. Headache. 2007;47(3):441–3.

    Article  PubMed  Google Scholar 

  47. Porta-Etessam J, Cuadrado M, Rodríguez-Gómez O, García-Ptacek S, Valencia C. Are Cox-2 drugs the second line option in indomethacin responsive headaches? J Headache Pain. 2010;11(5):405–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Miller S, Watkins L, Matharu MS. Treatment of intractable hemicrania continua by occipital nerve stimulation. J Neurol Neurosurg Psychiatry. 2017;88(9):805–6.

    Article  PubMed  Google Scholar 

  49. Nesbitt A, Marin J, Goadsby P. Treatment of hemicrania continua by non-invasive vagus nerve stimulation in 2 patients previously treated with occipital nerve stimulation. J Headache Pain. 2013;14(Suppl 1):P230-P.

    Google Scholar 

  50. Khalil M, Ahmed F. Hemicrania continua responsive to botulinum toxin type a: a case report. Headache. 2013;53(5):831–3.

    Article  PubMed  Google Scholar 

  51. Garza I, Cutrer FM. Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A. Cephalalgia. 2010;30(4):500–3.

    Article  CAS  PubMed  Google Scholar 

  52. Parveen S, Javed MA. Stevens Johnson syndrome associated with lamotrigine. Pak J Med Sci. 2013;29(6):1450–2.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia. 2004;24(11):985–92.

    Article  CAS  PubMed  Google Scholar 

  54. Wei DY, Jensen RH. Therapeutic approaches for the management of trigeminal autonomic cephalalgias. Neurotherapeutics. 2018;15(2):346–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Lambru G, Trimboli M, Palmisani S, Smith T, Al-Kaisy A. Safety and efficacy of cervical 10 kHz spinal cord stimulation in chronic refractory primary headaches: a retrospective case series. J Headache Pain. 2016;17(1):66.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Porta-Etessam J, Cuadrado ML, Galán L, Sampedro A, Valencia C. Temporal response to bupivacaine bilateral great occipital block in a patient with SUNCT syndrome. J Headache Pain. 2010;11(2):179.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Weng HY, Cohen AS, Schankin C, Goadsby PJ. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia. 2018;38(9):1554–63.

    Article  PubMed  Google Scholar 

  58. Pareja JA, Kruszewski P, Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades. Headache. 1995;35(3):138–42.

    Article  CAS  PubMed  Google Scholar 

  59. Graff-Radford SB. SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia. 2000;20(5):515–7.

    Article  CAS  PubMed  Google Scholar 

  60. Rossi P, Cesarino F, Faroni J, Malpezzi MG, Sandrini G, Nappi G. SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia. 2003;23(10):998–1000.

    Article  CAS  PubMed  Google Scholar 

  61. Lambru G, Matharu MS. SUNCT and SUNA: medical and surgical treatments. Neurol Sci. 2013;34(Suppl 1):S75–81.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA

    Amrita-Amanda D. Vuppala

  2. Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA

    Daniel Crespo & Amrita-Amanda D. Vuppala

Authors
  1. Daniel Crespo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amrita-Amanda D. Vuppala
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amrita-Amanda D. Vuppala .

Editor information

Editors and Affiliations

  1. Division of Neuro-Ophthalmology Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Amanda D. Henderson

  2. Division of Neuro-Ophthalmology Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Andrew R. Carey

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Crespo, D., Vuppala, AA.D. (2021). Trigeminal Autonomic Cephalgias. In: Henderson, A.D., Carey, A.R. (eds) Controversies in Neuro-Ophthalmic Management. Springer, Cham. https://doi.org/10.1007/978-3-030-74103-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74103-7_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74102-0

  • Online ISBN: 978-3-030-74103-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation